Organised by Germany, Harm Reduction International, UNAIDS, UNODC, WHO, the International HIV/AIDS Alliance, Open Society Foundations, IDPC, the International AIDS Society and AIDS Fonds Maria Phelan, HRI. We all know now that harm reduction works, but significant barriers remain today. We have a powerful panel today to explore the political positions on harm reduction and how …
World Health Organization (WHO)
UNGASS Roundtable 1: Demand reduction and related measures
Demand reduction and related measures, including prevention and treatment, as well as health-related issues; an ensuring the availability of controlled substances for medical and scientific purposes, while preventing their diversion. (‘Drugs and health’) Chair: in order to encourage an interactive discussion, this will be conducted without a list of speakers. All participants at round tables …
General Assembly: Thirtieth special session of the General Assembly on the world drug problem (Opening segment)
The full statements delivered by member states during the UNGASS general debate are available here. Mogens Lykketoft: Ladies and gentlemen, I think for the election as President of this special session. Let me express my condolences to the delegations of Ecuador and Japan whose countries have been hit by deadly earthquakes. It is an honour …
Side event – The public health elements of a comprehensive, balanced and inclusive drug policy.
Side event organised by the World Health Organisation. Dr Shekhar Saxena: welcome and thank you for coming. First question question to WHO: in the draft outcomes document, member states requested more involvement from the WHO, how is the WHO planning to do this? Marie-Paule Kieny, WHO. WHO warmly welcomes the push for the public health approach. It …
Agenda Item 6b: Changes in the scope of control
Documents: E/CN.7/2016/9 and E/CN.7/2016/CRP.2 Chair: Philippines informed the secretariat that it does not oppose the scheduling of any of the proposed substances. Commission will examine recommendations on the seven substances in accordance with the provisions of the 1971 convention, and should decide what action, if any, it wishes to take. Before moving on to a vote …
Agenda Item 6: Implementation of the international drug control treaties
a) Challenges and future work of the Commission on Narcotic Drugs and the World Health Organization in the review of substances for possible scheduling recommendations WHO: Who is responsible for evaluating substances and whether they should be scheduled. They also decided which convention they are scheduled. Evidence is essential to our role. The adverse affects of the …